GDF15 and cardiovascular disorder: Taking as a whole, this evidence strongly supports the hypothesis that GDF-15 is a reliable biomarker for cardiovascular risk in patients with metabolic and cardiovascular diseases [109,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167].